OBJECTIVE: The Pfcrt-gene encodes a transmembrane protein located in the Plasmodium falciparum digestive vacuole. Chloroquine resistant (CQR) strains of African and Southeast Asian origin carry the Pfcrt-haplotype (c72-76) CVIET, whereas most South American and Papua New Guinean CQR stains carry the SVMNT haplotype. METHOD: Eighty-eight samples from an area with reported in vivo Chloroquine and in vitro Amodiaquine-resistance were screened for the K76T mutation and their Pfcrt-haplotype (c72-76) using a new SSOP-ELISA. RESULTS: Hundred percent of the analysed samples showed the K76T mutation which is highly associated with in vivo drug failure. This very high rate of a CQR-marker is alarming in an area were CQ is still used as first line drug. The distribution of the three main Pfcrt-haplotypes was as follows: 68% CVIET, 31% SVMNT, 0% CVMNT. CONCLUSIONS: These data show, for the first time, the South American/PNG -haplotype (SVMNT) on mainland Southeast Asia. SVMNT-haplotype and others might be associated with a decreased efficacy of Amodiaquine and could therefore be potential markers for of amodiaquine resistance (AQR). If there is a correlation between AQR and the SVMNT-haplotype as suggested, 31% prevalence of a potential resistance marker is cause for concern.
OBJECTIVE: The Pfcrt-gene encodes a transmembrane protein located in the Plasmodium falciparum digestive vacuole. Chloroquine resistant (CQR) strains of African and Southeast Asian origin carry the Pfcrt-haplotype (c72-76) CVIET, whereas most South American and Papua New Guinean CQR stains carry the SVMNT haplotype. METHOD: Eighty-eight samples from an area with reported in vivo Chloroquine and in vitro Amodiaquine-resistance were screened for the K76T mutation and their Pfcrt-haplotype (c72-76) using a new SSOP-ELISA. RESULTS: Hundred percent of the analysed samples showed the K76T mutation which is highly associated with in vivo drug failure. This very high rate of a CQR-marker is alarming in an area were CQ is still used as first line drug. The distribution of the three main Pfcrt-haplotypes was as follows: 68% CVIET, 31% SVMNT, 0% CVMNT. CONCLUSIONS: These data show, for the first time, the South American/PNG -haplotype (SVMNT) on mainland Southeast Asia. SVMNT-haplotype and others might be associated with a decreased efficacy of Amodiaquine and could therefore be potential markers for of amodiaquine resistance (AQR). If there is a correlation between AQR and the SVMNT-haplotype as suggested, 31% prevalence of a potential resistance marker is cause for concern.
Authors: Rajeev K Mehlotra; Gabriel Mattera; Moses J Bockarie; Jason D Maguire; J Kevin Baird; Yagya D Sharma; Michael Alifrangis; Grant Dorsey; Philip J Rosenthal; David J Fryauff; James W Kazura; Mark Stoneking; Peter A Zimmerman Journal: Antimicrob Agents Chemother Date: 2008-04-14 Impact factor: 5.191
Authors: Juliana Martha Sá; Olivia Twu; Karen Hayton; Sahily Reyes; Michael P Fay; Pascal Ringwald; Thomas E Wellems Journal: Proc Natl Acad Sci U S A Date: 2009-11-02 Impact factor: 11.205
Authors: Mayfong Mayxay; Marion Barends; Alan Brockman; Anchalee Jaidee; Shalini Nair; Dan Sudimack; Tiengkham Pongvongsa; Samlane Phompida; Rattanaxay Phetsouvanh; Tim Anderson; Nicholas J White; Paul N Newton Journal: Am J Trop Med Hyg Date: 2007-02 Impact factor: 2.345
Authors: Bianca E Gama; Guilhermina A L Pereira-Carvalho; Florbela J I Lutucuta Kosi; Natália K Almeida de Oliveira; Filomeno Fortes; Philip J Rosenthal; Cláudio T Daniel-Ribeiro; Maria de Fátima Ferreira-da-Cruz Journal: Malar J Date: 2010-06-18 Impact factor: 2.979
Authors: Prashant K Mallick; Hema Joshi; Neena Valecha; Surya K Sharma; Alex Eapen; Rajendra M Bhatt; Harish C Srivastava; Patrick L Sutton; Aditya P Dash; Virendra K Bhasin Journal: Malar J Date: 2012-01-11 Impact factor: 2.979
Authors: Martin A Adjuik; Richard Allan; Anupkumar R Anvikar; Elizabeth A Ashley; Mamadou S Ba; Hubert Barennes; Karen I Barnes; Quique Bassat; Elisabeth Baudin; Anders Björkman; François Bompart; Maryline Bonnet; Steffen Borrmann; Philippe Brasseur; Hasifa Bukirwa; Francesco Checchi; Michel Cot; Prabin Dahal; Umberto D'Alessandro; Philippe Deloron; Meghna Desai; Graciela Diap; Abdoulaye A Djimde; Grant Dorsey; Ogobara K Doumbo; Emmanuelle Espié; Jean-Francois Etard; Caterina I Fanello; Jean-François Faucher; Babacar Faye; Jennifer A Flegg; Oumar Gaye; Peter W Gething; Raquel González; Francesco Grandesso; Philippe J Guerin; Jean-Paul Guthmann; Sally Hamour; Armedy Ronny Hasugian; Simon I Hay; Georgina S Humphreys; Vincent Jullien; Elizabeth Juma; Moses R Kamya; Corine Karema; Jean R Kiechel; Peter G Kremsner; Sanjeev Krishna; Valérie Lameyre; Laminou M Ibrahim; Sue J Lee; Bertrand Lell; Andreas Mårtensson; Achille Massougbodji; Hervé Menan; Didier Ménard; Clara Menéndez; Martin Meremikwu; Clarissa Moreira; Carolyn Nabasumba; Michael Nambozi; Jean-Louis Ndiaye; Frederic Nikiema; Christian Nsanzabana; Francine Ntoumi; Bernhards R Ogutu; Piero Olliaro; Lyda Osorio; Jean-Bosco Ouédraogo; Louis K Penali; Mbaye Pene; Loretxu Pinoges; Patrice Piola; Ric N Price; Cally Roper; Philip J Rosenthal; Claude Emile Rwagacondo; Albert Same-Ekobo; Birgit Schramm; Amadou Seck; Bhawna Sharma; Carol Hopkins Sibley; Véronique Sinou; Sodiomon B Sirima; Jeffery J Smith; Frank Smithuis; Fabrice A Somé; Doudou Sow; Sarah G Staedke; Kasia Stepniewska; Todd D Swarthout; Khadime Sylla; Ambrose O Talisuna; Joel Tarning; Walter R J Taylor; Emmanuel A Temu; Julie I Thwing; Emiliana Tjitra; Roger C K Tine; Halidou Tinto; Michel T Vaillant; Neena Valecha; Ingrid Van den Broek; Nicholas J White; Adoke Yeka; Issaka Zongo Journal: BMC Med Date: 2015-03-31 Impact factor: 8.775
Authors: Andreas G Nerlich; Bettina Schraut; Sabine Dittrich; Thomas Jelinek; Albert R Zink Journal: Emerg Infect Dis Date: 2008-08 Impact factor: 6.883